ALTACE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Altace, and when can generic versions of Altace launch?
Altace is a drug marketed by King Pharms Llc and King Pfizer and is included in two NDAs.
The generic ingredient in ALTACE is ramipril. There are nineteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ramipril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Altace
A generic version of ALTACE was approved as ramipril by WATSON LABS on October 24th, 2005.
Summary for ALTACE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 26 |
Patent Applications: | 3,436 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ALTACE |
Drug Sales Revenues: | Drug sales revenues for ALTACE |
What excipients (inactive ingredients) are in ALTACE? | ALTACE excipients list |
DailyMed Link: | ALTACE at DailyMed |



Recent Clinical Trials for ALTACE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
Ferrer Internacional S.A. | Phase 2 |
University of Nebraska | Phase 4 |
Pharmacology for ALTACE
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ALTACE
US Patents and Regulatory Information for ALTACE
Expired US Patents for ALTACE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-003 | Feb 27, 2007 | See Plans and Pricing | See Plans and Pricing |
King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-004 | Jan 28, 1991 | See Plans and Pricing | See Plans and Pricing |
King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-002 | Jan 28, 1991 | See Plans and Pricing | See Plans and Pricing |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-002 | Feb 27, 2007 | See Plans and Pricing | See Plans and Pricing |
King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-001 | Jan 28, 1991 | See Plans and Pricing | See Plans and Pricing |
King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-003 | Jan 28, 1991 | See Plans and Pricing | See Plans and Pricing |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALTACE
See the table below for patents covering ALTACE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 172751 | See Plans and Pricing | |
Germany | 3588198 | See Plans and Pricing | |
Canada | 1197252 | DERIVES DE L'ACIDE CIS, ENDO-2-AZABICYCLO-[3.3.0] -OCTANE-3-CARBOXYLIQUE; METHODE DE PREPARATION; AGENTS RENFERMANT CES COMPOSES ET LEUR UTILISATION (DERIVATIVES OF CIS, ENDO-2-AZABICYCLO-[3.3.0]- OCTANE-3-CARBOXYLIC ACID A PROCESS FOR THEIR PREPARATION, AGENTS CONTAINING THESE COMPOUNDS AND THEIR USE) | See Plans and Pricing |
Bulgaria | 60532 | See Plans and Pricing | |
Spain | 8308542 | See Plans and Pricing | |
Russian Federation | 2005141759 | See Plans and Pricing | |
Hungary | 0203326 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ALTACE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0050800 | 96C0028 | Belgium | See Plans and Pricing | PRODUCT NAME: PORFIMERE SODIQUE; NAT. REGISTRATION NO/DATE: NL 19150 19960409; FIRST REGISTRATION: NL - RVG 16652 19940411 |
0265685 | 99C0001 | Belgium | See Plans and Pricing | PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919 |
0079022 | SPC/GB93/145 | United Kingdom | See Plans and Pricing | SPC/GB93/145, EXPIRES: 20040109 |
0265685 | SPC/GB98/047 | United Kingdom | See Plans and Pricing | PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825 |
0265685 | C980030 | Netherlands | See Plans and Pricing | PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |